Category: Joint ventures/collaborations
-
Radiation, Biotech Companies Partner on Scar Therapy
Two companies taking different approaches to treating keloids — visible raised skin scars — are integrating their therapies to develop an anticipated treatment that removes and prevents the recurrence of these scars.
-
Pharma Maker Crowdsourcing for Drug Delivery Partners
The global pharmaceutical company AstraZeneca is looking for collaborators to develop treatments for disease using nucleic acids delivered with cell-penetrating peptides.
-
Microsoft Providing A.I. for Big Data Cancer Research
Seven research teams are receiving grants to study complex problems in cancer immunotherapy with large-scale data sets, and assistance with machine learning and artificial intelligence provided by Microsoft Corp.
-
Institute Using Software to Boost Results Reproducibility
A genomics research lab in the U.K. is adding software to automate data collection that its developer says can improve the productivity of scientists and reproducibility of their findings.
-
Institute, Company Partner on Implanted Neuro Device
A research center in Switzerland and medical engineering company in Germany are developing an implanted device to measure signals and treat disorders affecting the brain.
-
Limited Industry Progress Seen on Microbial Resistance
A pharmaceutical industry coalition documents some advances after 2 years in developing better products and practices against antimicrobial resistance, but progress is limited and uneven.
-
Nerve Stimulation Shown to Reduce Diabetes Symptoms
Electric stimulation of a key nerve pathway was shown in lab animals to restore insulin sensitivity and glucose tolerance typically missing in people with type 2 diabetes.
-
Medical Tech, Phone App Companies Partner on Wound Care
A company making wound care products is collaborating with a developer of mobile apps and analytics to design a more advanced diagnostics system for wounds.
-
Genomic Analysis Company Adds Body Composition Profiles
A company analyzing genomics and microbiome factors to extend human life spans is adding an evaluation of body composition to its tool kit.
-
Lilly, Tech Company Study Diabetes Experiences
A maker of diabetes drugs and digital health enterprise are beginning a study of real world experiences with self-management and education among people with diabetes.